Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence
2025 · JHEP Reports · 5 citations
https://doi.org/10.1016/j.jhepr.2025.101431
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
169
Citations
5
h-index
3
i10-index
Claudia Angela Maria Fulgenzi is an academic researcher from Hammersmith Hospital. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Colorectal Cancer Treatments and Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 5, co-authored 6 publications.
Click to start Chat